TDS Pharm Co (XKRX:464280) Inventories, Raw Materials & Components: ₩2,471 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:464280 TDS Pharm Co Ltd XKRX:464280
40 GF Score
Price ₩5,520.00
! 1 Warning Sign
View Full Analysis

What is TDS Pharm Co Inventories, Raw Materials & Components?

TDS Pharm Co XKRX:464280 40 Inventories, Raw Materials & Components is ₩2,471 Mil as of Jun. 2026. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review.

TDS Pharm Co's inventories, raw materials & components for the quarter that ended in Jun. 2026 was ₩2,471 Mil.

TDS Pharm Co's quarterly raw materials increased from Dec. 2025 (₩1,616 Mil) to Mar. 2026 (₩1,793 Mil) and increased from Mar. 2026 (₩1,793 Mil) to Jun. 2026 (₩2,471 Mil).

TDS Pharm Co's annual raw materials increased from Dec. 2023 (₩1,670 Mil) to Dec. 2024 (₩2,055 Mil) but then declined from Dec. 2024 (₩2,055 Mil) to Dec. 2025 (₩1,616 Mil).

TDS Pharm Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for TDS Pharm Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TDS Pharm Co Inventories, Raw Materials & Components Chart

TDS Pharm Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 1,538.31 1,635.36 1,670.07 2,055.46 1,615.71

TDS Pharm Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,057.16 1,776.39 1,615.71 1,793.30 2,471.49
XKRX:464280
40GF Score
TDS Pharm Co Ltd XKRX:464280
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TDS Pharm Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ₩2,471 Mil mean?
TDS Pharm Co (XKRX:464280) has a Inventories, Raw Materials & Components of ₩2,471 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on TDS Pharm Co and its competitors.
Is TDS Pharm Co's Inventories, Raw Materials & Components too high?
TDS Pharm Co's current Inventories, Raw Materials & Components is ₩2,471 Mil. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's Inventories, Raw Materials & Components compare to LLY and JNJ?
TDS Pharm Co's Inventories, Raw Materials & Components of ₩2,471 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on TDS Pharm Co and its competitors. TDS Pharm Co's current Inventories, Raw Materials & Components is ₩2,471 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current Inventories, Raw Materials & Components of ₩2,471 Mil. The current Inventories, Raw Materials & Components is ₩2,471 Mil. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current Inventories, Raw Materials & Components is ₩2,471 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TDS Pharm Co Business Description

Address 253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score

Get the complete analysis for XKRX:464280

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩5,520.00
Price